clinical trial · NCT07264959
An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
Indolent Systemic Mastocytosis
brief summary
This is a Phase 4, non-interventional, observational study to collect detailed data on the clinical characteristics, clinical outcomes and medical management of ISM in real-world settings. The study will describe the demographic and clinical characteristics of ISM participants, including anaphylaxis and bone manifestations in ISM. Quality of life and disease control will be assessed through participant questionnaires. The study will also evaluate real world ISM treatment management, including use of avapritinib.
started
Apr 15, 2026
primary completion
Dec 1, 2032
completion
Dec 1, 2032
last updated
Apr 22, 2026
official title
An Observational Study in Patients With Indolent Systemic Mastocytosis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol